Changes of Soft Tissue Grafting: A Randomized Study
Launched by TUFTS UNIVERSITY · Nov 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Changes of Soft Tissue Grafting: A Randomized Study," is looking at new ways to treat gum recession, a condition where the gums pull away from the teeth, exposing the roots. The usual treatment involves taking tissue from the roof of a patient's mouth and placing it where the gums have receded. However, some patients may not want to go through another surgery or use donor tissue from others. This study is exploring the use of a special membrane made from the patient’s own blood as an alternative treatment option.
To be eligible for the trial, participants need to be at least 18 years old and have gum recession that requires treatment at two or more sites in their mouth. Certain conditions, like smoking or being pregnant, will exclude individuals from participating. Those who join the study will help researchers understand if using this blood-derived membrane can effectively treat gum recession while avoiding the need for additional surgical sites. This is an exciting opportunity for patients who are looking for a less invasive way to improve their gum health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults 18yrs or older
- • 2. Need of MG-tx for 2 or more sites for root coverage RT I and II (Cairo classification)
- • 3. Class A +/-
- • 4. No class V restoration present
- Exclusion Criteria:
- • 1. Patients who do not consent to recommended therapy
- • 2. Patients who smoke
- • 3. Patients who will not be able to comply with follow up protocols
- • 4. Those who self report that they are pregnant.
About Tufts University
Tufts University is a prestigious research institution renowned for its commitment to advancing health and medicine through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Tufts leverages its expertise in biomedical research, public health, and clinical practice to design and conduct rigorous studies that address critical health challenges. The university's clinical trial programs are characterized by their adherence to high ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the scientific community. Through its dedication to fostering education and research, Tufts University plays a vital role in translating findings into effective health interventions and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Tannaz Shapurian, DMD, MSc
Principal Investigator
Tufts University School of Dental Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials